ESH Acquisition Corp Class A Common Stock (ESHA) has the highest short ratio by a US stock in the Nasdaq Composite (IXIC), with 3,647 shares short representing 125.76 times average daily trading volume.
| ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
|---|---|---|---|---|
ESH Acquisition Corp Class A Common Stock (ESHA) | 3,647 | 829,763 | 0.36% | 125.76 |
BeyondSpring (BYSI) | 2.1415M | 30.2887M | 7.5% | 79.94 |
Old Market Capital (OMCC) | 136,945 | 2.9435M | 4.09% | 70.08 |
Immutep Ltd ADR (IMMP) | 4.2308M | 1.2282B | 2.96% | 57.44 |
Cartesian Therapeutics (RNAC) | 2.3675M | 9.3903M | 22.88% | 42.57 |
Yoshitsu Co Ltd ADR (TKLF) | 191,363 | 13.3679M | 10.78% | 37.94 |
Bowen Acquisition Corp Ordinary Shares (BOWN) | 4,095 | 367,679 | 1.08% | 34.7 |
RumbleON (RMBL) | 1.9648M | 12.0425M | 11.71% | 33.41 |
Design Therapeutics (DSGN) | 3.5082M | 23.335M | 9.32% | 31.69 |
Tyra Biosciences (TYRA) | 5.7457M | 17.2192M | 15.79% | 30.09 |
Immunocore (IMCR) | 8.8111M | 37.5726M | 24.09% | 29.45 |
Wrap Technologies (WRAP) | 5.3292M | 36.4999M | 15.26% | 29.44 |
Oruka Therapeutics (ORKA) | 4.3045M | 22.4082M | 18.41% | 29.09 |
Molecular Partners AG ADR (MOLN) | 30,817 | 15.4041M | 0.17% | 28.22 |
Inhibikase Therapeutics (IKT) | 3.2934M | 24.9667M | 10.91% | 27.96 |
Tucows (TCX) | 543,486 | 5.7059M | 8.13% | 27.81 |
Sonder (SOND) | 1.2203M | 11.701M | 10.47% | 26.98 |
Galectin Therapeutics (GALT) | 7.9635M | 44.9254M | 20.69% | 26.16 |
Spyre Therapeutics (SYRE) | 13.1876M | 46.7352M | 28.03% | 25.91 |
Forafric Global PLC Ordinary Shares (AFRI) | 272,235 | 3.2819M | 5% | 24.29 |
BioAge Labs (BIOA) | 2.4016M | 24.3088M | 7.87% | 24.29 |
Erasca (ERAS) | 18.8086M | 167.4589M | 7.52% | 23.67 |
Coherus BioSciences (CHRS) | 32.7278M | 111.1864M | 29.28% | 23.41 |
Fennec Pharmaceuticals (FENC) | 1.2796M | 14.5643M | 6.63% | 22.53 |
ArriVent BioPharma, Inc Common Stock (AVBP) | 6.7012M | 21.6041M | 22.08% | 22.46 |
